. Author manuscript; available in PMC: 2010 Dec 29.

Published in final edited form as: Am J Physiol Heart Circ Physiol. 2008 Feb 15;294(4):H1630–H1637. doi: 10.1152/ajpheart.01314.2007

Table 1A.

Baseline characteristics in group 1

	GnRHa	GnRHa+E2	GnRHa+E2+MPA	P Value
Estradiol, pg/ml	22.1±1.4^*	157.9±27.0	175.2±25.7	<0.001
Progesterone, ng/ml	0.85±0.11	0.77±0.08	0.73±0.07	0.159
FSH, mIU/ml	4.91±1.06^*	1.99±0.43	1.71±0.48	<0.001
LH, mIU/ml	0.53±0.14	0.36±0.09	0.35±0.07	0.198
Blood pressure, mmHg
Systolic	114±2	114±2	112±2	0.115
Diastolic	74±2	74±2	72±2	0.368
Mean arterial	87±2	87±2	85±2	0.160
Heart rate, beats/min	64±3	62±3	63±3	0.453

Values are means ± SE; n = 10 subjects. GnRHa, gonadotropin-releasing hormone antagonist; E₂, 17β-estradiol; MPA, medroxyprogesterone acetate; FSH, follicle-stimulating hormone; LH, luteinizing hormone.

Significant difference, GnRHa vs. GnRHa+E₂ and GnRHa+E₂+MPA.